advances in surgery for inflammatory bowel disease

43
Advances in Surgery Advances in Surgery for Inflammatory for Inflammatory Bowel Disease Bowel Disease Joel J. Bauer, M.D.

Upload: others

Post on 24-Jun-2022

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Advances in Surgery for Inflammatory Bowel Disease

Advances in Surgery Advances in Surgery

for Inflammatory for Inflammatory

Bowel DiseaseBowel Disease

Joel J. Bauer, M.D.

Page 2: Advances in Surgery for Inflammatory Bowel Disease

The Ideal Surgical Procedure The Ideal Surgical Procedure for Ulcerative Colitisfor Ulcerative Colitis

��Complete eradication of Complete eradication of diseasedisease

��Preservation of physiologic Preservation of physiologic functionfunction

��Restoration of quality of lifeRestoration of quality of life

Page 3: Advances in Surgery for Inflammatory Bowel Disease
Page 4: Advances in Surgery for Inflammatory Bowel Disease
Page 5: Advances in Surgery for Inflammatory Bowel Disease
Page 6: Advances in Surgery for Inflammatory Bowel Disease

RPCRPC� 1475 cases since 1980

� 1062 cases 7/87-10/08

–136 Standard mucosectomy

–829 Minimally Traumatic Mucosectomy• 194 with ileostomy

• 635 without ileostomy–377 one stage 258 STC/RPC

–97 double staple

Page 7: Advances in Surgery for Inflammatory Bowel Disease

Overall ResultsOverall Results19871987--20082008

�Patients 87-present 1075

�Peri-op mortality 3 (0.3%)

� Late mortality 22 (2.0%)

�Pouch removed 60 (5.6%)

� Ileostomy in situ 47 (4.4%)

� Incomplete data 309 (28.7%)

�Data available 634 (59.0%)

Page 8: Advances in Surgery for Inflammatory Bowel Disease

Controversies:Controversies:Unresolved Unresolved

�� MucosectomyMucosectomy vs.vs. no no mucosectomymucosectomy

�� AnastomosisAnastomosis: sewn : sewn vs.vs. stapledstapled

�� IleostomyIleostomy vs.vs. no no ileostomyileostomy

�� The The ““agedaged”” patient: RPC patient: RPC vs.vs. no RPCno RPC

�� Cancer: RPC Cancer: RPC vs.vs. no RPCno RPC

Page 9: Advances in Surgery for Inflammatory Bowel Disease

Criteria For Criteria For IleostomyIleostomy

OmissionOmission�� Favorable nonFavorable non--urgent surgery in fit urgent surgery in fit

patientpatient

�� Ideally off steroids, or at least, low dose Ideally off steroids, or at least, low dose

((≤≤20mg prednisone)20mg prednisone)

�� Adequate mesenteric lengthAdequate mesenteric length

�� No pelvic contaminationNo pelvic contamination

�� Good Good hemostasishemostasis

�� Sutured, airSutured, air--tight tight anastomosisanastomosis

�� Tube decompressionTube decompression

Page 10: Advances in Surgery for Inflammatory Bowel Disease

RPC Without DiversionRPC Without Diversion

MSH

2000

Sew

Edinburgh

1998

Staple

Leeds

1997

Staple

Boston

1995

Staple

Virginia

1994

Staple

CCF

1993

Staple

Toronto

1992

Staple

Cases 375 72 50 68 68 50 71

Sepsis/leak 26

(6.8%)

6

(8.3%)

11

(22%)

5

(7.4%)

10

(14.7%)

7

(14%)

13

(18%)

Secondary

diversion

21

(5.6%)

6

(8.3%)

7

(14%)

4

(5.9%)

5

(7.3%)

3

(6%)

1

(1.4%)

Failure 14

(3.7%)

? 3

(6%)

0 0 ? ?

Excise

Pouch

5

(1.4%)

? 0 2

(3%)

0 ? 0

Page 11: Advances in Surgery for Inflammatory Bowel Disease

Practice/Mount Sinai Series Practice/Mount Sinai Series

19871987--20082008

�� 1063 pouches1063 pouches

�� 710 (66.9%) had no 710 (66.9%) had no ileostomyileostomy at RPCat RPC

�� 968 (91.1%) hand968 (91.1%) hand--sewn with sewn with

mucosectomymucosectomy

RPC Without DiversionRPC Without Diversion

Page 12: Advances in Surgery for Inflammatory Bowel Disease

Safety and Efficacy ofSafety and Efficacy of

SingleSingle--Stage RPCStage RPC::A Review OF 350 CasesA Review OF 350 Cases

� To evaluate the clinical outcomes and safety of Restorative Proctocolectomy without diverting ileostomy in a large series of patients with Ulcerative Colitis

Chessin DB, Bauer,JJ, Bub, DS, Gorfine SR, J. ACS, submitted

Page 13: Advances in Surgery for Inflammatory Bowel Disease

Preoperative Preoperative

ImmunomodulatorsImmunomodulators

Immunomodulator N (%)

Prednisone 171 (49.0%)

Median Dose of Prednisone 16.8 (0-60) mg

6-Mercaptopurine 113 (62.3%)

Cyclosporine 30 (8.6%)

Page 14: Advances in Surgery for Inflammatory Bowel Disease

ComplicationsComplications

Complication N (%)Anastomotic Leak 27 (7.7%)

Wound Infection 23 (6.6%)

DVT/PE 8 (2.3%)

Small Bowel

Obstruction

67 (19.1%)

Pouch Excision 9 (2.6%)

Page 15: Advances in Surgery for Inflammatory Bowel Disease

PregnancyPregnancyAttempted n=46Attempted n=46

Conceived n=33 (67%)Conceived n=33 (67%)

Did Not Conceive

Conceived

No Stoma 11 15 (57.7%) p=0.128

Stoma 4 16 (80.0%)

No Leak 10 25 (71.4%) p=0.462

Leak 5 6 (54.5%)

Page 16: Advances in Surgery for Inflammatory Bowel Disease

Pregnancy• Following restorative proctocolectomy,

–74% of women who desired pregnancy

were able to conceive

»However, 35% required medical assistance to conceive

–No clinical, pathologic, or postoperative factors were identified as predictors of a successful pregnancy

Chessin DB,,Gorfine SR,,Bauer JJ et al. Dis Colon Rectum, submitted

Page 17: Advances in Surgery for Inflammatory Bowel Disease

Pouchitis

55%9%

22%

9%5%

Never

1-2 episodes

Multiple episodes

chronic, constant meds

chronic despite meds

Page 18: Advances in Surgery for Inflammatory Bowel Disease

RPC SummaryRPC Summary� Excellent functional results

–6-7 BM/24 hrs

–Perfect or near perfect control in

~90%

� Mucosection

–Reduces/eliminates risk of

proctitis/cancer

–Excellent functional results

Page 19: Advances in Surgery for Inflammatory Bowel Disease

ConclusionsConclusions

�� AnastomoticAnastomotic leak following RPC:leak following RPC:

––Does not adversely affect longDoes not adversely affect long--

term quality of life or functional term quality of life or functional

outcomeoutcome

––Does not increase the incidence Does not increase the incidence

of pouchitisof pouchitis

––Does not decrease fertilityDoes not decrease fertility

Page 20: Advances in Surgery for Inflammatory Bowel Disease

ConclusionsConclusions

�� The overall rate of pouch failure The overall rate of pouch failure

among among undivertedundiverted patients is 5.6%patients is 5.6%

�� The overall rate of pouch excision The overall rate of pouch excision

among among undivertedundiverted patients is 3.8%patients is 3.8%

�� Pouch failure is more common after Pouch failure is more common after

anastomoticanastomotic leakage leakage

Page 21: Advances in Surgery for Inflammatory Bowel Disease

RESTORATIVE

PROCTOCOLECTOMY FOR

ULCERATIVE COLITIS

COMPLICATED BY

COLORECTAL CANCER

Stephen R. Gorfine, MD, Michael T. Harris, MD, David S. Bub, MD, Joel J. Bauer, MD

ASCRS June1997

ASCRS June 2003

Dis. Col. Rect 2004

Page 22: Advances in Surgery for Inflammatory Bowel Disease

Results

� 46 (5.8%) RPC patients had

colorectal carcinoma complicating

CUC

� 26 (56.5%) cases were known or

suspected preoperatively

Page 23: Advances in Surgery for Inflammatory Bowel Disease

Conclusions

�RPC can achieve satisfactory oncologic

results in selected CUC patients with

“early” cancers

�Adjuvant chemotherapy can be

administered to diverted and non-diverted

Page 24: Advances in Surgery for Inflammatory Bowel Disease

Is Laparoscopy a Is Laparoscopy a

Safe and Useful Safe and Useful

Approach to RPC?Approach to RPC?

Page 25: Advances in Surgery for Inflammatory Bowel Disease

Laparoscopic Laparoscopic

Assisted RPCAssisted RPC� First reported in 1992

� Theoretical advantages– Less pain

– Less blood loss

– Fewer adhesions– Shorter hospital stay

– Faster return to work

– Better cosmetic results

Peters J et al. Laparoendosc Surg 1992;2:175-8

Page 26: Advances in Surgery for Inflammatory Bowel Disease

Features of Surgery (CUC)Features of Surgery (CUC)

� True Pfannensteil Incision

� Insert Hand Port, If Indicated

� Laparoscopic Mobilization of Flexures

� Stapled J-Pouch

� Mucosectomy vs. No Mucosectomy

� Stapled vs. Hand-Sewn Anastomosis

Page 27: Advances in Surgery for Inflammatory Bowel Disease

Recent StudyRecent Study

� To compare laparoscopic to open

RPC to determine

� Safety and feasibility of laparoscopic

RPC

• Short-term postoperative complications

• Need for ileostomy

Patricia Sylla MD, David B. Chessin MD, Stephen R. Gorfine MD, Esther Roth BA, David S. Bub MD, and Joel J. Bauer MD. Dis Colon Rectum,

March 2009; 394-9.

Page 28: Advances in Surgery for Inflammatory Bowel Disease

MaterialsMaterials

�252 cases

11/98-7/06

�196 open:56

lapa

Page 29: Advances in Surgery for Inflammatory Bowel Disease

ConclusionsConclusions�Patients undergoing

laparoscopic-assisted RPC were

–Younger

–Had a lower BMI

–More often female

Page 30: Advances in Surgery for Inflammatory Bowel Disease

ConclusionsConclusions� Laparoscopic-assisted RPC is

associated with

– Less blood loss than open RPC

– Longer operative time

� Sepsis occurred more frequently in

laparoscopic-assisted RPC patients

� Other complications and LOS were

similar compared to the open group

Page 31: Advances in Surgery for Inflammatory Bowel Disease
Page 32: Advances in Surgery for Inflammatory Bowel Disease
Page 33: Advances in Surgery for Inflammatory Bowel Disease
Page 34: Advances in Surgery for Inflammatory Bowel Disease
Page 35: Advances in Surgery for Inflammatory Bowel Disease

Laparoscopic-Assisted

Intestinal Resection for

Crohn’s DiseaseJoel J. Bauer, M.D., Michael T. Harris, M.D., Nicholas M.

Grumbach, B.A., Stephen R. Gorfine, M.D.

From the Department of Surgery, Mount Sinai School of

Medicine, New York, New York

Dis Colon Rectum 1995;35:712-715

“On the basis of this initial study, it appears that

laparoscopic dissection and resection in patients with Crohn’s disease are both safe and readily

accomplished in selected patients.”

Page 36: Advances in Surgery for Inflammatory Bowel Disease

Laparoscopic-Assisted Intestinal Resection

(378 Patients)

2

53147

176

Non-IBD Crohn's Disease

Ulcerative Colitis Indeterminate Colitis

Page 37: Advances in Surgery for Inflammatory Bowel Disease

Features of Surgery Features of Surgery

(CD)(CD)� Identification of Diseased Segments

� Mobilization of Bowel to be Resected

– Lateral Peritoneal Attachments

– Ileocolic Angle

– Fistulae and Attachments to Normal Tissue• Unaffected Bowel

• Bladder

• Body Wall

• Pelvic Adnexae

Page 38: Advances in Surgery for Inflammatory Bowel Disease

Features of Surgery Features of Surgery

(Cont.)(Cont.)�Selection of Incision

�Extracorporeal Ligation and Division of Mesenteric Vessels

�Extracorporeal Anastomosis

�Closure of Mesenteric Defect

�Drain

Page 39: Advances in Surgery for Inflammatory Bowel Disease

LaparoscopicLaparoscopic––Assisted Assisted IleocolicIleocolic

Resection for CrohnResection for Crohn’’s Diseases Disease

� 131 Patients

–36 with Recurrent Disease (27.5%)

–33 Requiring Concomitant

Procedures (25.2%)

• 19 Fistula Divisions

• 16 Abscess Drainages

• 14 Additional ResectionsEdden Y., Ciardullo J., Sherafgan W., Harris MT., Bub DS., Gorfine SR., Bauer JJ.Laparoscopic-Assisted Ileocolic Resection for Crohn’s Disease: Experience with 158 Patients. Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons. 2008 Apr-Jun;12(2):139-42.

Page 40: Advances in Surgery for Inflammatory Bowel Disease

Postoperative Length Postoperative Length

of Stayof Stay� Laparoscopic-Assisted Ileocolic

Resection (n=131)–Mean 5.84 Days

� Early Control Group (n=14)

–Mean 8.50 Days (p<.005)

� Open Ileocolic Resection (n=341)

–Mean 7.87 Days (p<.0003)

Page 41: Advances in Surgery for Inflammatory Bowel Disease

ComplicationsComplications

�No difference in the rate of

major or minor

complications between open

and laparoscopic-assisted

procedures in all three

groups.

Page 42: Advances in Surgery for Inflammatory Bowel Disease

ConclusionsConclusions

� Laparoscopic-Assisted Intestinal Resection is Feasible and Safe in Patients with Crohn’s Disease and Ulcerative Colitis

� Postoperative Length of Stay is Significantly Reduced in Patients Undergoing Lap-Assisted IleocolicResection for Crohn’s Disease

Page 43: Advances in Surgery for Inflammatory Bowel Disease

ConclusionsConclusions

�Laparoscopic-Assisted

Ileocolic Resection is Now

the Operation of Choice for

Most Patients Undergoing

Surgery for Crohn’s Disease